Biosyent Inc (RX.V)
9.05
-0.05
(-0.55%)
CAD |
TSXV |
May 31, 16:00
Biosyent Profit Margin (Quarterly): 22.87% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 22.87% |
| December 31, 2023 | 17.54% |
| September 30, 2023 | 26.50% |
| June 30, 2023 | 18.63% |
| March 31, 2023 | 18.13% |
| December 31, 2022 | 16.08% |
| September 30, 2022 | 21.40% |
| June 30, 2022 | 18.36% |
| March 31, 2022 | 22.56% |
| December 31, 2021 | 26.01% |
| September 30, 2021 | 25.73% |
| June 30, 2021 | 13.97% |
| March 31, 2021 | 22.43% |
| December 31, 2020 | 11.63% |
| September 30, 2020 | 16.56% |
| June 30, 2020 | 15.14% |
| March 31, 2020 | 23.94% |
| December 31, 2019 | 20.97% |
| September 30, 2019 | 24.64% |
| June 30, 2019 | 13.40% |
| March 31, 2019 | 21.84% |
| December 31, 2018 | 28.28% |
| September 30, 2018 | 24.16% |
| June 30, 2018 | 27.42% |
| March 31, 2018 | 25.70% |
| Date | Value |
|---|---|
| December 31, 2017 | 24.69% |
| September 30, 2017 | 23.96% |
| June 30, 2017 | 27.55% |
| March 31, 2017 | 23.59% |
| December 31, 2016 | 21.85% |
| September 30, 2016 | 26.17% |
| June 30, 2016 | 23.22% |
| March 31, 2016 | 25.23% |
| December 31, 2015 | 19.85% |
| September 30, 2015 | 25.58% |
| June 30, 2015 | 23.68% |
| March 31, 2015 | 29.12% |
| December 31, 2014 | 24.63% |
| September 30, 2014 | 27.55% |
| June 30, 2014 | 28.93% |
| March 31, 2014 | 20.89% |
| December 31, 2013 | 25.93% |
| September 30, 2013 | 26.19% |
| June 30, 2013 | 23.41% |
| March 31, 2013 | 22.34% |
| December 31, 2012 | 37.91% |
| September 30, 2012 | 27.12% |
| June 30, 2012 | 27.75% |
| March 31, 2012 | 30.20% |
| December 31, 2011 | 9.27% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
11.63%
Minimum
Dec 2020
26.50%
Maximum
Sep 2023
19.82%
Average
19.80%
Median
Profit Margin (Quarterly) Benchmarks
| Biocure Technology Inc | -- |
| Core One Labs Inc | -897.6% |
| Nova Mentis Life Science Corp | -649.3% |
| Nanosphere Health Sciences Inc | -- |
| Lobe Sciences Ltd | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 20.67% |
| Return on Assets | 17.45% |
| Return on Invested Capital | 20.55% |
| Gross Profit Margin (Quarterly) | 79.44% |
| Operating Margin (Quarterly) | 27.03% |
| Return on Net Operating Assets | 41.63% |